Title |
Rapid development of an inactivated vaccine for SARS-CoV-2
|
---|---|
Published in |
bioRxiv, April 2020
|
DOI | 10.1101/2020.04.17.046375 |
Authors |
Qiang Gao, Linlin Bao, Haiyan Mao, Lin Wang, Kangwei Xu, Minnan Yang, Yajing Li, Ling Zhu, Nan Wang, Zhe Lv, Hong Gao, Xiaoqin Ge, Biao Kan, Yaling Hu, Jiangning Liu, Fang Cai, Deyu Jiang, Yanhui Yin, Chengfeng Qin, Jing Li, Xuejie Gong, Xiuyu Lou, Wen Shi, Dongdong Wu, Hengming Zhang, Lang Zhu, Wei Deng, Yurong Li, Jinxing Lu, Changgui Li, Xiangxi Wang, Weidong Yin, Yanjun Zhang, Chuan Qin |
X Demographics
The data shown below were collected from the profiles of 4,177 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 654 | 16% |
Spain | 295 | 7% |
United Kingdom | 185 | 4% |
Ireland | 112 | 3% |
Peru | 101 | 2% |
Brazil | 75 | 2% |
Canada | 75 | 2% |
India | 72 | 2% |
Japan | 61 | 1% |
Other | 639 | 15% |
Unknown | 1908 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3408 | 82% |
Scientists | 549 | 13% |
Practitioners (doctors, other healthcare professionals) | 135 | 3% |
Science communicators (journalists, bloggers, editors) | 85 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 241 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 241 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 59 | 24% |
Student > Ph. D. Student | 32 | 13% |
Student > Bachelor | 28 | 12% |
Other | 15 | 6% |
Student > Master | 14 | 6% |
Other | 34 | 14% |
Unknown | 59 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 42 | 17% |
Medicine and Dentistry | 26 | 11% |
Immunology and Microbiology | 25 | 10% |
Agricultural and Biological Sciences | 25 | 10% |
Engineering | 10 | 4% |
Other | 41 | 17% |
Unknown | 72 | 30% |